Alpha-amylase variants with altered properties

Details for Australian Patent Application No. 2005259686 (hide)

Owner Novozymes A/S

Inventors Ostdal, Henrik; Andersen, Carsten; Skagerlind, Peter

Agent Shelston IP

Pub. Number AU-B-2005259686

PCT Pub. Number WO2006/002643

Priority PA 2004 01325 02.09.04 DK; PA 2004 01059 05.07.04 DK

Filing date 5 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 23 December 2010

International Classifications

C12N 15/56 (2006.01) Mutation or genetic engineering - acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme

C11D 3/386 (2006.01) Other compounding ingredients of detergent compositions covered in group

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/28 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

D06M 16/00 (2006.01) Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic

C12R 1/07 (2006.01)

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002643 Priority application(s): WO2006/002643

23 December 2010 Application Accepted

  Published as AU-B-2005259686

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259689-Novel carbamylated EPO and method for its production

2005259685-Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids